HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W C Stewart Selected Research

Brimonidine Tartrate (Alphagan)

11/2008Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
1/2005Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
10/2004Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
7/2004Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.
6/2001Washout periods for brimonidine 0.2% and latanoprost 0.005%.
6/2001Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
5/2001The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
12/2000Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
6/2000Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
6/2000Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W C Stewart Research Topics

Disease

25Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2009 - 02/2000
14Ocular Hypertension (Glaucoma, Suspect)
05/2009 - 06/2000
11Glaucoma
10/2010 - 02/2000
5Hyperemia
03/2008 - 05/2001
4Exfoliation Syndrome
09/2004 - 02/2000
1Low Tension Glaucoma
09/2008
1Hypersensitivity (Allergy)
09/2004
1Pain (Aches)
09/2004
1Dizziness (Lightheadedness)
01/2003
1Bradycardia
01/2003
1Pruritus (Itching)
06/2000

Drug/Important Bio-Agent (IBA)

19Timolol (Blocadren)FDA LinkGeneric
10/2010 - 02/2000
18Latanoprost (Xalatan)FDA Link
10/2010 - 06/2000
11dorzolamide (Trusopt)FDA LinkGeneric
11/2008 - 02/2000
10Brimonidine Tartrate (Alphagan)FDA LinkGeneric
11/2008 - 06/2000
4Bimatoprost (Lumigan)FDA Link
09/2008 - 05/2001
3Travoprost (Travatan)FDA Link
10/2010 - 11/2006
2brinzolamide (Azopt)FDA Link
11/2006 - 09/2004
2SolutionsIBA
06/2001 - 02/2000
1ProstaglandinsIBA
03/2008
1isopropyl unoprostone (Rescula)FDA Link
03/2001
1Pilocarpine (Ocusert)FDA LinkGeneric
02/2001
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
06/2000
1Dihydrotachysterol (AT 10)IBA
02/2000

Therapy/Procedure

8Therapeutics
01/2009 - 02/2000
1Drug Therapy (Chemotherapy)
10/2000